Clinical TrialID 6902
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00390403
Brain and Central Nervous System Tumors
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6902
- Evidence Id
- 6902
- Core Evidence Id
- 6902
- Source Clinical Trial Id
- 6894
- Herb2 Clinical Trial Id
- HBCT006894
- Nct Id
- NCT00390403
- Title
- Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Brain and Central Nervous System Tumors
- Study Type
- Interventional
- Study Design
- Allocation: NON_RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: R-(-)-gossypol acetic acid|DRUG: temozolomide|GENETIC: gene expression analysis|GENETIC: mutation analysis|GENETIC: protein expression analysis|OTHER: laboratory biomarker analysis|OTHER: pharmacological study|PROCEDURE: adjuvant therapy|RADIATION: radiation therapy
- Intervention Allocation
- Non_Randomized
- Intervention Model
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 50
- Outcome Measure
- Maximum tolerated dose
- Sponsor Collaborator
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI)
- Funded By
- OTHER
- Location
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama, 35294, United States|H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, 33612-9497, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, 30322, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, 21231-2410, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, 48202, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, 27157-1096, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, 44195, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104-4283, United States
- Other Id
- NABTT-0602 CDR0000507451|U01CA062475|NABTT-0602
- Start Date
- 2007-02
- Primary Completion Date
- 2009-06
- Completion Date
- First Posted
- 2006-10-19
- Results First Posted
- Last Update Posted
- 2012-05-03
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00390403
- Title Cn
- Title En
- Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Bilingual Status
- semi_complete